Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Med Microbiol Immunol ; 202(5): 379-89, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23722593

RESUMEN

Aspergillus terreus-induced invasive infections exhibit high lethality, partly due to the intrinsic resistance for amphotericin B (AmB). We compared the virulence and pathogenesis of an AmB-resistant isolate of A. terreus (ATR) with that of a rare variant showing enhanced sensitivity for AMB (ATS). The modifications that result in enhanced AmB sensitivity of isolates are not associated with reduced virulence in vivo; instead, the ATS-infected mice died even faster than the ATR-infected animals. Since A. terreus enters the blood stream in most patients and frequently induces thrombosis, we studied a putative correlation between virulence of the two A. terreus isolates and their effect on thrombocytes. Those mice infected with the more virulent ATS isolate had lower thrombocyte numbers and more phosphatidylserine exposure on platelets than ATR-infected mice. In vitro experiments confirmed that ATS and ATR differ in their effect on thrombocytes. Conidia, aleurioconidia and hyphae of ATS were more potent than ATR to trigger thrombocyte stimulation, and thrombocytes adhered better to ATS than to ATR fungal structures. Furthermore, ATS secreted more soluble factors that triggered platelet stimulation than ATR. Thus, it might be suggested that the capacity of a fungal isolate to modulate thrombocyte parameters contributes to its virulence in vivo.


Asunto(s)
Anfotericina B/farmacología , Antifúngicos/farmacología , Aspergilosis/microbiología , Aspergilosis/patología , Aspergillus/patogenicidad , Plaquetas/microbiología , Animales , Aspergillus/efectos de los fármacos , Plaquetas/fisiología , Adhesión Celular , Modelos Animales de Enfermedad , Farmacorresistencia Fúngica , Femenino , Voluntarios Sanos , Humanos , Ratones , Ratones Endogámicos BALB C , Análisis de Supervivencia , Trombocitopenia , Virulencia
2.
Electrophoresis ; 32(13): 1684-91, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21647922

RESUMEN

Blue native electrophoresis (BNE) was applied to analyze the von Willebrand factor (vWF) multimers in their native state and to present a methodology to perform blue native electrophoresis on human plasma proteins, which has not been done before. The major difference between this method and the commonly used SDS-agarose gel electrophoresis is the lack of satellite bands in the high-resolution native gel. To further analyze this phenomenon, a second dimension was performed under denaturing conditions. Thereby, we obtained a pattern in which each protein sub-unit from the first dimension dissociates into three distinct sub-bands. These bands confirm the triplet structure, which consists of an intermediate band and two satellite bands. By introducing the second dimension, our novel method separates the triplet structure into a higher resolution than the commonly used SDS-agarose gel electrophoresis does. This helps considerably in the classification of ambiguous von Willebrand's disease subtypes. In addition, our method has the additional advantage of being able to resolve the triplet structure of platelet vWF multimers, which has not been identified previously through conventional SDS-agarose electrophoresis multimer analysis. This potential enables us to compare the triplet structure from platelet and plasmatic vWF, and may help to find out whether structural abnormalities concern the vWF molecule in the platelet itself, or whether they are due to the physiological processing of vWF shed into circulation. Owing to its resolution and sensitivity, this native separation technique offers a promising tool for the analysis and detection of von Willebrand disorder, and for the classification of von Willebrand's disease subtypes.


Asunto(s)
Plaquetas/química , Electroforesis en Gel de Agar/métodos , Complejos Multiproteicos/química , Enfermedades de von Willebrand/clasificación , Factor de von Willebrand/química , Electroforesis en Gel de Poliacrilamida , Humanos , Complejos Multiproteicos/análisis , Desnaturalización Proteica , Subunidades de Proteína , Factores de Tiempo , Enfermedades de von Willebrand/sangre , Factor de von Willebrand/análisis
3.
Acta Otolaryngol ; 126(3): 291-4, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16618657

RESUMEN

CONCLUSIONS: The combination of N-chlorotaurine (NCT) and a corticosteroid seems to be a very promising substance for the local therapy of ENT infections. As it can be used without any preservatives, the effect on the ciliary beat frequency (CBF) is much less than that of products containing benzalkonium chloride (BAC). The in vitro results obtained in this study encourage us to perform clinical trials on this novel combination for intranasal application. OBJECTIVE: To investigate the influence of a novel mixture of NCT and a corticosteroid [fluticasone propionate (FP)] on the CBF of human ciliated cells in vitro. MATERIAL AND METHODS: The study was designed as an in vitro study. CBF was measured by means of a photometric technique involving the combination of a light microscope, a photometer, a photographic multiplier and a computerized analyzing unit. RESULTS: The combination of 1% NCT + 0.5 mg/ml FP decreased the CBF to 42.17% of its original value after 20 min. Treatment with BAC lowered the CBF depending on the concentration to 96.61% of its original value with 0.04 mg/ml, to 91.90% with 0.1 mg/ml, to 63.46% with 0.2 mg/ml and to 0% with 0.5 mg/ml. After rinsing in saline, the CBF of samples treated with 1% NCT + 0.5 mg/ml FP recovered to 68.93% of its original value.


Asunto(s)
Androstadienos/farmacología , Antiinfecciosos Locales/farmacología , Depuración Mucociliar/efectos de los fármacos , Mucosa Nasal/citología , Taurina/análogos & derivados , Células Cultivadas , Cilios/efectos de los fármacos , Desinfectantes , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Fluticasona , Humanos , Técnicas In Vitro , Dosis Máxima Tolerada , Sensibilidad y Especificidad , Taurina/farmacología
4.
Thromb Haemost ; 105(1): 72-80, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20978717

RESUMEN

Dickkopf-3 (Dkk3) has been proposed as tumour suppressor gene and a marker for tumour blood vessels. We analysed the expression and function of Dkk3 in platelets and megakaryocytes from healthy controls and patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN). Dkk3 protein and gene expression in platelets was compared with endothelial and other blood cell populations by ELISA, real-time PCR, and immunofluorescence. Moreover, megakaryocytes were isolated from bone marrow aspirates by CD61 microbeads. Immunohistochemical studies of Dkk3 expression were performed in essential thrombocythemia (ET), polycythemia vera (PV), primary myelofibrosis (PMF) and control reactive bone marrow cases (each n=10). Compared to all other blood cell populations platelets showed the highest concentration of Dkk3 protein (150 ± 19 ng/mg total protein). A strong DKK3 gene and protein expression was also observed in isolated megakaryocytes. Dkk3 co-localised with VEGF in α-granules of platelets and was released similar to VEGF upon stimulation. Addition of recombinant Dkk3 had no influence on blood coagulation (aPTT, INR) and platelet aggregation. Significantly more Dkk3+ megakaryocytes/mm2 could be found in bone marrow biopsies from patients with MPN (ET 40 ± 10, PV 31 ± 4, PMF 22 ± 3) than in controls (15 ± 3). The mean proportion of Dkk3+ megakaryocytes was increased in MPN as well (ET 83% ± 15%; PV 84% ± 12%; PMF 77% ± 8%) compared to controls (53% ± 11%). Dkk3+ megakaryocytes correlated with microvessel density in PV and PMF. We conclude that Dkk3 might be involved in the pathogenesis of MPN.


Asunto(s)
Plaquetas/química , Péptidos y Proteínas de Señalización Intercelular/análisis , Megacariocitos/química , Trastornos Mieloproliferativos/metabolismo , Proteínas de Neoplasias/análisis , Proteínas Adaptadoras Transductoras de Señales , Adulto , Biomarcadores de Tumor/análisis , Células Sanguíneas/química , Examen de la Médula Ósea , Capilares , Estudios de Casos y Controles , Células Cultivadas , Quimiocinas , Humanos , Inmunohistoquímica , Péptidos y Proteínas de Señalización Intercelular/farmacología , Trastornos Mieloproliferativos/patología , Policitemia Vera/metabolismo , Policitemia Vera/patología , Mielofibrosis Primaria/metabolismo , Mielofibrosis Primaria/patología , Trombocitemia Esencial/metabolismo , Trombocitemia Esencial/patología , Factor A de Crecimiento Endotelial Vascular/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA